The Pharma Navigator
  • All News
  • Previous Issues
  • Events
  • About Us
  • Advertise
  • Contact Us
Login Register
list_articles_topic_releted_img

Regulatory Dealmaking Supply chain

EMA Finalizes Draft Guidance on Real-World Data Integration

4 min read • 2 hours ago
list_articles_topic_releted_img

Future Biopharma

Trump’s cuts to foreign aid are undermining the Ebola response, insiders

4 min read • 2 hours ago
list_articles_topic_releted_img

Regulatory Dealmaking Supply chain

Interchangeability standards are under examination in the forthcoming Senate hearing.

4 min read • 2 hours ago
list_articles_topic_releted_img

Future Biopharma

Dexcom CEO hints at future uses for CGM

4 min read • 2 hours ago
list_articles_topic_releted_img

Regulatory Dealmaking Supply chain

How AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.

4 min read • 2 hours ago
  • Account
  • Language
    • English English
    • Russian Russian
    • Chinese Chinese
    • Korean Korean
    • Japanese Japanese
Login Register
  • Discovery & Development
    • Small Molecule
    • Large Molecule
    • Early Phase
    • APIs & Ingredients
  • Manufacturing & Operations
    • Solid/Semi-Solid Dose
    • Parenterals
    • Sterile/Aseptic
    • Supply Chain & Logistics
    • Analytics
  • Outsourcing & Partnerships
    • Formulation Services
    • Manufacturing Services
    • Regulatory Services
    • Analytical Services
  • Drug Delivery & Packaging
    • Drug Delivery Devices
    • Primary Packaging
    • Secondary Packaging
  • Regulatory & Compliance
    • U.S.
    • Europe
    • RoW
  • Strategy & Business
    • M&A
    • Funding & Investments
    • Start Ups
  • Multimedia & Events
    • All Points of the Pharma Compass
    • Charting the Best Course
    • From Stem to Stern
    • Conference Coverage
  • Sponsored Resources
    • Articles
    • Videos
    • White Papers

54 results for ‘Start Ups’

RELATED:
Strategy & Business Funding & Investments Manufacturing Services
  • Eli Lilly Sees GLP-1 Success, Highlights Ongoing Challenges
    Funding & Investments

    Eli Lilly Sees GLP-1 Success, Highlights Ongoing Challenges

    4 min read • 2 years ago
  • Zealand Pharma Raises $1 Billion to Develop Obesity Drugs
    Funding & Investments

    Zealand Pharma Raises $1 Billion to Develop Obesity Drugs

    4 min read • 2 years ago
  • Simtra Commences Work on Bloomington Facility Expansion
    News

    Simtra Commences Work on Bloomington Facility Expansion

    4 min read • 2 years ago
  • Lotte Biologics and Merck KGaA Partner to Boost Biopharma Production
    Manufacturing Services

    Lotte Biologics and Merck KGaA Partner to Boost Biopharma Production

    4 min read • 2 years ago
  • Takeda Restructures, Cuts Early-Stage Drug Programs
    Funding & Investments

    Takeda Restructures, Cuts Early-Stage Drug Programs

    4 min read • 2 years ago
  • Takeda, Astellas, and SMBC Launch Strategic Alliance for Drug Discovery
    Start Ups

    Takeda, Astellas, and SMBC Launch Strategic Alliance for Drug Discovery

    4 min read • 2 years ago
  • Pathios Therapeutics Raises BMS-led Series B Funding
    Manufacturing Services

    Pathios Therapeutics Raises BMS-led Series B Funding

    4 min read • 2 years ago
  • Bora Completes Acquisition of US-Based Upsher-Smith
    M&A

    Bora Completes Acquisition of US-Based Upsher-Smith

    4 min read • 2 years ago
  • Amgen’s MariTide Challenges Weight Loss Drug Market with Innovative Approach and Promising Early Results
    Discovery & Development

    Amgen’s MariTide Challenges Weight Loss Drug Market with Innovative Approach and Promising Early Results

    4 min read • 2 years ago
  • Novo Nordisk’s Wegovy Approved by the FDA for Heart Attack & Stroke Prevention
    Regulatory & Compliance

    Novo Nordisk’s Wegovy Approved by the FDA for Heart Attack & Stroke Prevention

    4 min read • 3 years ago
  • ‹
  • 1
  • …
  • 4
  • 5
  • 6
  • ›

RECENT SEARCHES

Clear
  • No recent searches yet.
The Pharma Navigator

Stay Ahead of the Curve

Join 45,000+ industry professionals who rely on our clinical precision and editorial authority.

INTELLIGENCE

  • Market Intel
  • R&D Pipeline
  • Regulatory Tracker
  • Deal Flow

NETWORK

  • Events
  • Podcasts
  • Previous Issues
  • About Us

COMPANY

  • Advertise
  • Contact Us
  • Editorial Policy

CONNECT

  • Social 1
  • Social 2
  • Social 3

© 2026 The Pharma Navigator. Clinical Precision. Editorial Authority.

  • Privacy Policy
  • Terms and Conditions
  • Editorial Standards
  • Contact
Valsynthese advertisement

Subscribe to our newsletter

Complete your details to receive pharma intelligence and executive briefings.

✓

Thank you for subscribing.

Your newsletter subscription has been received successfully.